Literature DB >> 26448669

Montelukast: Chronic Urticaria.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2015        PMID: 26448669      PMCID: PMC4589848          DOI: 10.1310/hpj5007-583

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  5 in total

Review 1.  The diagnosis and management of acute and chronic urticaria: 2014 update.

Authors:  Jonathan A Bernstein; David M Lang; David A Khan; Timothy Craig; David Dreyfus; Fred Hsieh; Javed Sheikh; David Weldon; Bruce Zuraw; David I Bernstein; Joann Blessing-Moore; Linda Cox; Richard A Nicklas; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Diane E Schuller; Sheldon L Spector; Stephen A Tilles; Dana Wallace
Journal:  J Allergy Clin Immunol       Date:  2014-05       Impact factor: 10.793

2.  Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.

Authors:  Gabriele Di Lorenzo; Maria Luisa Pacor; Pasquale Mansueto; Maria Esposito Pellitteri; Claudia Lo Bianco; Vito Ditta; Nicola Martinelli; Giovam Battista Rini
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

3.  Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.

Authors:  Kong-Sang Wan
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

4.  Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.

Authors:  E Nettis; M C Colanardi; M T Paradiso; A Ferrannini
Journal:  Clin Exp Allergy       Date:  2004-09       Impact factor: 5.018

5.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.